Table 3.
Comparison of baseline clinical characteristics between non‐ER group and ER group
| Non‐ER group (N = 99) | ER group (N = 34) | P‐value | |
|---|---|---|---|
| Male, % | 49 | 35 | .23 |
| Age, yr | 56 ± 11 | 60 ± 8 | .12 |
| Body mass index, kg/m2 | 24.2 ± 2.5 | 24.6 ± 2.6 | .49 |
| Smoking habit, % | 32 | 21 | .31 |
| Alcohol habit, % | 67 | 41 | .01 |
| Hypertension, % | 36 | 55 | .10 |
| Diabetes mellitus, % | 5 | 4 | 1.00 |
| Heart disease, % | 7 | 10 | .80 |
| Antihypertensive drugs, % | 26 | 50 | .01 |
| No. of antihypertensive drugs | 1.5 ± 0.7 | 1.8 ± 1.0 | .31 |
| CCB, % | 84 | 88 | 1.00 |
| ACEI/ARB, % | 52 | 35 | .45 |
| β‐Blocker, % | 12 | 0 | .38 |
| Diuretics, % | 8 | 6 | 1.00 |
| Siesta habit, % | 40 | 46 | .77 |
| LDL cholesterol, mg/dL | 117.8 ± 29.8 | 126.8 ± 21.0 | .12 |
| HDL cholesterol, mg/dL | 58.8 ± 14.8 | 54.7 ± 10.5 | .14 |
| Triglyceride, mg/dL | 137.0 ± 101.2 | 137.5 ± 56.3 | .97 |
| Fasting blood sugar, mg/dL | 100.3 ± 25.3 | 101.9 ± 15.9 | .74 |
| eGFR, mL/min/1.73 m2 | 64.3 ± 14.6 | 56.4 ± 14.5 | .01 |
| baPWV, mm/sec | 1489.1 ± 332.2 | 1603.2 ± 306.2 | .07 |
| 24 h | |||
| Systolic BP, mm Hg | 125.9 ± 16.4 | 129.2 ± 13.1 | .28 |
| Diastolic BP, mm Hg | 77.4 ± 8.8 | 79.2 ± 8.4 | .28 |
| Heart rate, bpm | 69.2 ± 7.4 | 68.8 ± 6.6 | .77 |
| Awake‐ | |||
| Systolic BP, mm Hg | 131.7 ± 15.5 | 134.8 ± 12.3 | .31 |
| Diastolic BP, mm Hg | 80.6 ± 9.2 | 82.6 ± 8.4 | .25 |
| Heart rate, bpm | 71.9 ± 7.8 | 73.1 ± 7.2 | .44 |
| Asleep‐ | |||
| Systolic BP, mm Hg | 112.9 ± 16.2 | 117.9 ± 16.0 | 013 |
| Diastolic BP, mm Hg | 68.4 ± 9.1 | 71.5 ± 9.7 | .07 |
| Heart rate, bpm | 62.3 ± 7.8 | 61.4 ± 6.6 | .52 |
Abbreviation: ER, evening rise. Other abbreviations as in Table 1.